Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Amyloidosis Discovery Trial

NCT06469372 is registered in ClinicalTrials.gov with Pierre Elias as lead sponsor.

NCT NCT06469372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Amyloidosis Discovery Trial
Lead sponsor
Pierre Elias
Phase
Not applicable
Overall status
Completed
Start date
May 28, 2024
Completion date
August 1, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis